13.12.2024
Publications category: Pharmacometrics
09.12.2024
Population pharmacokinetic analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia
20.11.2024
Integrated modeling of biomarkers, survival and safety in clinical oncology drug development
12.11.2024
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia
11.11.2024
Bimekizumab population pharmacokinetic and exposure-response analyses in adults with moderate to severe hidradenitis suppurativa
11.11.2024
The impact of misspecified covariate models on inclusion and omission bias when using FREM and FFEM
11.11.2024
Exposure-efficacy analysis of datopotamab deruxtecan (Dato-DXd), a TROP2-directed antibody-drug conjugate, in patients with advanced non-small cell lung cancer
11.11.2024
Phase 1 interim population PK/PD modeling and recommended phase 2 dose exploration for IMM-1-104: A novel concept oral deep cyclic inhibitor of MEK
11.11.2024
The reference corrected VPC (rcVPC) – an informative model diagnostics for assessing underying exposure-response relationships
07.10.2024
Population pharmacokinetic and dose–response models of nepadutant, a selective antagonist of the NK₂ receptors, in infants with colic
02.07.2024